false
OasisLMS
zh-CN,zh-TW,en,fr,de,ja,ko,pt,es,th,vi
Catalog
Classification Investigation - Examining Pathogeni ...
Classification Investigation
Classification Investigation
Back to course
[Please upgrade your browser to play this video content]
Video Transcription
Video Summary
The recent webinar titled "Classification Investigation: Examining Pathogenicity of DMD Variants Detected on Carrier Screening" provided educational insights into the complex challenges of carrier screening, specifically focusing on DMD gene variants. Attendees were informed about the intricacies of genetic counseling related to DMD variants, emphasizing expanded carrier screening's impact on such cases. Presenters, including Blake Vuccolo, Kayla Banks, and Sandra Darcilik, shared case studies illustrating the varied implications of DMD variants detected through expanded carrier screening.<br /><br />A notable case involved an individual identified with a pathogenic DMD variant affecting family planning decisions. Despite the variant's pathogenic classification, a male family member carrying the same variant exhibited no related health issues, raising questions about its real-world implications. Discussions highlighted the importance of thorough familial testing, particularly in the absence of a dystrophinopathy family history, to better assess the variant's pathogenicity. This case exemplified the complexities arising when pathogenic variants, typically expected to be clinically significant, do not manifest anticipated symptoms.<br /><br />The panel underscored the need for cautious interpretation of screened variants and recommended diligent family history analysis to avoid unnecessary medical interventions. They also discussed current practices and recommendations around carrier screening, emphasizing the dissonance between professional guidelines and insurance coverage challenges. The session concluded by acknowledging the necessity for ongoing dialogue and research within the genetics community to improve variant classification and provide accurate counseling, urging genetic professionals to consider the broader implications of identified DMD variants.
Keywords
DMD variants
carrier screening
genetic counseling
pathogenicity
family planning
dystrophinopathy
familial testing
medical interventions
insurance coverage
genetics community
×